Auvelity (Dextromethorphan-Bupropion) for Agitation and Aggression in Alzheimer's Disease Dementia: Mechanism, Efficacy, Safety, and Clinical Considerations.
Psychopharmacology bulletin · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansDextromethorphanAlzheimer DiseaseDrug CombinationsPsychomotor AgitationAggressionBupropionCytochrome P-450 CYP2D6 InhibitorsAlzheimer’s diseaseBPSD (Behavioral and psychological symptoms of dementia)NMDA receptor antagonistagitationauvelitydextromethorphan-bupropion
Come citare questo studio
Mridul Sarangal, Charmi Sarangal, Jay Vora, Karishma Soni. (2026). Auvelity (Dextromethorphan-Bupropion) for Agitation and Aggression in Alzheimer's Disease Dementia: Mechanism, Efficacy, Safety, and Clinical Considerations.. Psychopharmacology bulletin. DOI: 10.64719/pb.20773
Consulta la pubblicazione originale ↗